China VC Watch: Genome, Diagnostics Ventures Attract New Funding

 
• By Brian Yang

Genetron Health is the latest emerging Chinese biotech to attract new capital in the push toward precision medicine in China, while the Lilly Asia Fund is among the investors in cancer diagnosis venture Singlera’s Series A.

currency
China pours money into molecular diagnostics investments • Source: Shutterstock

More from Asia

More from Geography